Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0985420080300010223
Laboratory Medicine and Quality Assurance
2008 Volume.30 No. 1 p.223 ~ p.228
Clinical Usefulness of Fecal Cytokeratin-19 Assay with Rapid Test
Lee Je-Hoon

Kim Myung-Shin
Lim Ji-Hyang
Kim Yong-Goo
Han Kyung-Ja
Yoon Sang-Soon
Abstract
Background: The fecal occult blood test (FOBT) is presently the only laboratory test for screening a population for colorectal cancer. However, the effectiveness of FOBT to reduce the mortality from colorectal cancer is still controversial. The cytokeratin-19 (CK-19) is highly expresssed in gastrointestinal (GI) epithelium. Therefore, fecal CK-19 excretion could be increased in gastrointestinal diseases.

Methods: We estimated fecal CK-19 using cytokeratin-19 enzyme-linked immunosorbent assay (Roche Diagnostics, Mannheim, Germany) on 53 stool samples from patients with various GI diseases and 100 stool samples from control patients. We conducted a study of rapid fecal CK-19 test using gold immunochromatography developed by DiNonA Research Institute (Seoul, Korea) and the fecal occult blood test (FOBT) on 115 stool samples from patients with various GI diseases and 181 stool samples from control patients.

Results: The cutoff value of fecal CK-19 was 408.7 pg/80mg. The sensitivity of the rapid fecal CK-19 kit was 10,000 epithelial cells /ml. The positive rate of rapid fecal CK-19 test was 4.4% in the controls, 83.9% in the thrombotic microangiopathy patients after BMT and it was higher than the positive rate of FOBT (58.1%, P=0.0264). In the overall GI diseases including GI cancers, the sensitivity of rapid fecal CK-19 test was 56.5%, and that of FOBT was 21.7%. The specificity of rapid fecal CK-19 test was 95.6%.

Conclusions: The rapid fecal CK-19 test in conjunction with the FOBT could be a valuable screening method for GI diseases especially for GI inflammation.
KEYWORD
Cytokeratin-19, Fecal occult blood test, Gastrointestinal disease, Colorectal cancer
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø